Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,645 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. Parving HH, et al. Among authors: Andersen S. N Engl J Med. 2001 Sep 20;345(12):870-8. doi: 10.1056/NEJMoa011489. N Engl J Med. 2001. PMID: 11565519 Clinical Trial.
Glomerular permselectivity in early stages of overt diabetic nephropathy.
Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD. Andersen S, et al. Kidney Int. 2000 Nov;58(5):2129-37. doi: 10.1111/j.1523-1755.2000.00386.x. Kidney Int. 2000. PMID: 11044234 Clinical Trial.
Evolving strategies for renoprotection: diabetic nephropathy.
Parving HH, Hovind P, Rossing K, Andersen S. Parving HH, et al. Among authors: Andersen S. Curr Opin Nephrol Hypertens. 2001 Jul;10(4):515-22. doi: 10.1097/00041552-200107000-00006. Curr Opin Nephrol Hypertens. 2001. PMID: 11458033 Review.
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH. Schjoedt KJ, et al. Among authors: Andersen S. Diabetologia. 2004 Nov;47(11):1936-9. doi: 10.1007/s00125-004-1542-0. Epub 2004 Nov 17. Diabetologia. 2004. PMID: 15551047 Clinical Trial.
Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.
Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, Jensen TM, Finnerup NB, Jensen TS, Lauritzen T, Feldman EL, Callaghan BC, Charles M. Andersen ST, et al. Among authors: Andersen H. Diabetes Care. 2018 May;41(5):1068-1075. doi: 10.2337/dc17-2062. Epub 2018 Feb 27. Diabetes Care. 2018. PMID: 29487078
Serum uric acid and progression of diabetic nephropathy in type 1 diabetes.
Pilemann-Lyberg S, Lindhardt M, Persson F, Andersen S, Rossing P. Pilemann-Lyberg S, et al. Among authors: Andersen S. J Diabetes Complications. 2018 May;32(5):470-473. doi: 10.1016/j.jdiacomp.2018.02.002. Epub 2018 Feb 15. J Diabetes Complications. 2018. PMID: 29534864 Clinical Trial.
Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark.
Andersen ST, Witte DR, Andersen H, Bjerg L, Bruun NH, Jørgensen ME, Finnerup NB, Lauritzen T, Jensen TS, Tankisi H, Charles M. Andersen ST, et al. Among authors: Andersen H. Diabetes Care. 2018 Sep;41(9):1955-1962. doi: 10.2337/dc18-0392. Epub 2018 Jul 9. Diabetes Care. 2018. PMID: 29987164
Risk of DPN was estimated by multivariate logistic regression models of each individual's risk-factor trajectory intercept and slope adjusting for sex, age, diabetes duration, height, and trial randomization group. ...
Risk of DPN was estimated by multivariate logistic regression models of each individual's risk-factor trajectory intercept and slope …
1,645 results
Jump to page
Feedback